Basit öğe kaydını göster

dc.contributor.authorVandecasseye, Willy
dc.contributor.authorFryns, Jean-Pierre
dc.contributor.authorSciot, Raf
dc.contributor.authorMassa, Guy
dc.contributor.authorDenayer, Ellen
dc.contributor.authorDevriendt, Koen
dc.contributor.authorde Ravel, Thomy
dc.contributor.authorVan Buggenhout, Griet
dc.contributor.authorSmeets, Eric
dc.contributor.authorFrancois, Inge
dc.contributor.authorSznajer, Yves
dc.contributor.authorCraen, Margarita
dc.contributor.authorLeventopoulos, George
dc.contributor.authorMutesa, Leon
dc.contributor.authorKayserili, Hulya
dc.contributor.authorLegius, Eric
dc.date.accessioned2021-03-05T16:48:45Z
dc.date.available2021-03-05T16:48:45Z
dc.date.issued2010
dc.identifier.citationDenayer E., Devriendt K., de Ravel T., Van Buggenhout G., Smeets E., Francois I., Sznajer Y., Craen M., Leventopoulos G., Mutesa L., et al., "Tumor Spectrum in Children With Noonan Syndrome and SOS1 or RAF1 Mutations", GENES CHROMOSOMES & CANCER, cilt.49, ss.242-252, 2010
dc.identifier.issn1045-2257
dc.identifier.othervv_1032021
dc.identifier.otherav_c270188d-23c0-469e-ba78-aec771835337
dc.identifier.urihttp://hdl.handle.net/20.500.12627/129046
dc.identifier.urihttps://doi.org/10.1002/gcc.20735
dc.description.abstractNoonan syndrome (NS) is an autosomal dominant disorder caused by mutations in PTPN11, KRAS, SOS1, and RAF1 We performed SOS1, RAF1, BRAF MEK1, and MEK2 mutation analysis in a cohort of 102 PTPN11- and KRAS-negative NS patients and found pathogenic SOS1 mutations in 10, RAF1 mutations in 4, and BRAF mutations in 2 patients. Three novel SOS1 mutations were found. One was classified as a rare benign variant and the other remains unclassified. We confirm a high prevalence of pulmonic stenosis and ectodermal abnormalities in SOS1-positive patients. Three patients with SOS1 mutations presented with tumors (embryonal rhabdomyosarcoma, Sertoli cell testis tumor, and granular cell tumors of the skin). One patient with a RAF1 mutation had a lesion suggestive for a giant cell tumor. This is the first report describing different tumor types in ISIS patients with germ line SOS1 mutations. (C) 2009 Wiley-Liss, Inc.
dc.language.isoeng
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectTıbbi Genetik
dc.subjectYaşam Bilimleri
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectTemel Bilimler
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectGENETİK VE HAYAT
dc.subjectMoleküler Biyoloji ve Genetik
dc.titleTumor Spectrum in Children With Noonan Syndrome and SOS1 or RAF1 Mutations
dc.typeMakale
dc.relation.journalGENES CHROMOSOMES & CANCER
dc.contributor.departmentKU Leuven , ,
dc.identifier.volume49
dc.identifier.issue3
dc.identifier.startpage242
dc.identifier.endpage252
dc.contributor.firstauthorID195493


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster